BRAND POSITIONING

Singapore HereMOM was founded in 2016, focusing on the research and application of HMOs, which are the original human nutrients.

The strength from MOM, is not detrimental to its own transmission.
In the pursuit of life's secrets, we will ultimately find ourselves returning to the roots of our being.

We believe in Original Strength and trust that every mother, with confidence and love, can provide her baby with Original Nutrition.

BRAND SCIENCE
Sustainable[1] PhermentTM Technology[2]

The HereMOM Singapore team adheres to the concept of sustainable nutritional technology. Collaborating with global top-tier scientific teams, they utilize advanced fermentation techniques to restore a variety of breast milk key HMOs.This process awakens original strength and establishes the high quality, high safety Sustainable Phermen™ scientific foundation.

[1] Refers to obtaining high-purity HMOs through precision fermentation technology and applying them to infant and young child nutritional products.
[2] Refers to the proprietary technology exclusively developed by HereMOM's scientific team. This patented technology centers on precision fermentation, optimizing and reconstructing microbial metabolic networks to produce high-purity HMOs through fermentation, separation, concentration, and purification processes.
Original Nutrition
HMOs, which build the essence of breast milk, are the No. 1 repairing active immune nutrition for infant growth and development.[1]
HMOs, or Human Milk Oligosaccharides, are the most abundant bioactive components in breast milk and the third largest solid nutrient, following lactose and fat. They are also the key differentiating nutrients between human milk and the milk of other mammals.[2]
[1] Research progress on the effects of human milk oligosaccharides on infant intestinal flora。DOI:10.3760/cma.j.cn101070-20210721-00853
[2] Human milk oligosaccharides: every baby needs a sugar mama.DOI:10.1093/glycob/cws074
  • 130 years ago, the scientific exploration of HMOs began.
  • At the end of the 19th century, a carbohydrate fraction specific to human milk was isolated. In parallel, a growth-promoting factor for Bifidobacterium was identified in human milk and referred to as the “bifidus factor.”
  • In 1954, human milk carbohydrate fraction and Bifidobacterium growth-promoting factor identified as HMO.
  • In 2000, 200+ HMOs isolated and characterized from human milk.
  • In 2012, the first HMO was produced with fermentation.
  • To date, HMOs have been approved or marketed in more than 160 countries and regions worldwide, including Europe, the United States, Asia-Pacific, the Middle East and Latin America.
Singapore is one of the early countries in the world to adopt a regulatory license for HMOs.
In 2016, HereMOM was established in Singapore to explore and apply the life secrets of HMOs.
In 2023, HereMOM successfully developed its 6HMOs Shield Essence based on HMO formulation.
0
years of breast milk
research
0+
invention patents
0+
research papers
0+
core products in
application
0+
HMO function explorations
More...
More core ingredients are continuously
obtaining patent certifications and testing
across multiple countries.